BackClearmind Medicine Overview

Clearmind Medicine Operating Income

Track Clearmind Medicine's operating income ($-10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1571209.00
20.22% YoY

As of Apr 30, 2026

Annual Operating Income (TTM)

$-10014786.00
92.15% YoY

Trailing 12 months ending Apr 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Clearmind Medicine (CMND) FAQ

As of the most recent data (April 2026), CMND shows a operating income of $-10M. That compares with $-5.2M in the prior-year period — down 92.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMND's operating income is now $-10M (was $-5.2M) — a 92.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Clearmind Medicine is outperforming or lagging.

Tracking CMND's operating income over time shows whether Clearmind Medicine is scaling, shrinking, or reshaping that part of the business. The current reading is $-10M That compares with $-5.2M in the prior-year period — down 92.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Clearmind Medicine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-10M) with ownership activity and broader fundamentals.

Clearmind Medicine's operating income is $-10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.